2 Clinical Trials Show Experimental Dengue Vaccine Safe, Effective Among Children Despite Previous Disease Exposure
CIDRAP News: Hopeful results from trials of dengue vaccine candidate
“Phase 2 and 3 randomized, controlled clinical trials of Takeda’s tetravalent (four-strain) dengue vaccine candidate show that it is safe, produces immunity in children, and protects against the disease — regardless of previous exposure to different strains of the virus, according to studies published [Tuesday in] The Lancet…” (Beusekom, 3/18).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.